Acetylation of lactate dehydrogenase B drives NAFLD progression by impairing lactate clearance

Lactate has recently been reported to accumulate in the livers of patients progressing from simple steatosis to non-alcoholic steatohepatitis (NASH). However, the underlying mechanism(s) of lactate accumulation and the role of lactate in the progression of non-alcoholic fatty liver disease (NAFLD) a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of hepatology 2021-05, Vol.74 (5), p.1038
Hauptverfasser: Wang, Tongxin, Chen, Kai, Yao, Weilei, Zheng, Ruilong, He, Qiongyu, Xia, Jun, Li, Juan, Shao, Yafei, Zhang, Li, Huang, Lu, Qin, Longshan, Xu, Mingming, Zhang, Zheng, Pan, Dingyu, Li, Zhen, Huang, Feiruo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 5
container_start_page 1038
container_title Journal of hepatology
container_volume 74
creator Wang, Tongxin
Chen, Kai
Yao, Weilei
Zheng, Ruilong
He, Qiongyu
Xia, Jun
Li, Juan
Shao, Yafei
Zhang, Li
Huang, Lu
Qin, Longshan
Xu, Mingming
Zhang, Zheng
Pan, Dingyu
Li, Zhen
Huang, Feiruo
description Lactate has recently been reported to accumulate in the livers of patients progressing from simple steatosis to non-alcoholic steatohepatitis (NASH). However, the underlying mechanism(s) of lactate accumulation and the role of lactate in the progression of non-alcoholic fatty liver disease (NAFLD) are essentially unknown. We compared the acetylome in liver samples taken from healthy individuals, patients with simple steatosis and patients with NASH to identify potential targets of acetylation with a role in lactate metabolism. Interactions between the acetylated target and acetyltransferases were measured in multiple cell lines. An acetyltransferase inhibitor was injected into high-fat diet (HFD)-fed mice to determine the role of lactate on NAFLD progression in vivo. Hyperacetylation of lactate dehydrogenase B (LDHB) was found to be associated with lactate accumulation in NAFL and NASH livers in humans and mice. P300/CBP-associated factor (PCAF)-mediated acetylation of LDHB K82 was found to significantly decrease LDHB activity and impair hepatic lactate clearance, resulting in lactate accumulation. Acetylated LDHB induced lactate accumulation which exacerbated lipid deposition and inflammatory responses by activating histone hyperacetylation in HFD-induced NASH. The administration of embelin, a PCAF inhibitor, and the generation of an acetylation-deficient mutant of LDHB ameliorated NASH. PCAF-dependent LDHB acetylation plays a key role in hepatic lipid accumulation and inflammatory responses by impairing lactate clearance; this process might be a potential therapeutic target for the treatment of NASH. Lactate is known to accumulate in the livers of patients during the progression of non-alcoholic fatty liver disease (NAFLD); however, the underlying mechanism(s) of this accumulation and its importance in disease progression are unknown. Herein, we show that the acetylation of an enzyme involved in lactate metabolism leads to impaired lactate clearance and exacerbates NAFLD progression.
doi_str_mv 10.1016/j.jhep.2020.11.028
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2465447600</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2553567910</sourcerecordid><originalsourceid>FETCH-LOGICAL-c288t-e122d5eca50b41e440532b35d3bb6d673f6a7636f7b097d00ad9a4db0ad427803</originalsourceid><addsrcrecordid>eNpdkDtPw0AQhE8IRELgD1AgSzQ0NntP22UIBJAiaKDFOvvWiS2_8NlI_vdcRKCgWmnnm9XsEHJJIaBA1W0ZlDvsAgbMLWgALDoic6oAfFCCHpO5gyI_YmE0I2fWlgDAIRanZMY5E5ET5-RjmeEwVXoo2sZrc6_S2aAH9AzuJtO3W2y0Re_OM33xhdZ7Wa43917nhB6t3XvSySvqThd90Wz_3FmFutdNhufkJNeVxYvDXJD39cPb6snfvD4-r5YbP2NRNPhIGTMSMy0hFRSFAMlZyqXhaaqMCnmudKi4ysMU4tAAaBNrYVI3hXsP-ILc_Nx10T5HtENSFzbDqtINtqNNmFBSiNB149Drf2jZjn3j0iVMSi5VGNM9dXWgxrRGk3R9Uet-Sn6b49925HCA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2553567910</pqid></control><display><type>article</type><title>Acetylation of lactate dehydrogenase B drives NAFLD progression by impairing lactate clearance</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Wang, Tongxin ; Chen, Kai ; Yao, Weilei ; Zheng, Ruilong ; He, Qiongyu ; Xia, Jun ; Li, Juan ; Shao, Yafei ; Zhang, Li ; Huang, Lu ; Qin, Longshan ; Xu, Mingming ; Zhang, Zheng ; Pan, Dingyu ; Li, Zhen ; Huang, Feiruo</creator><creatorcontrib>Wang, Tongxin ; Chen, Kai ; Yao, Weilei ; Zheng, Ruilong ; He, Qiongyu ; Xia, Jun ; Li, Juan ; Shao, Yafei ; Zhang, Li ; Huang, Lu ; Qin, Longshan ; Xu, Mingming ; Zhang, Zheng ; Pan, Dingyu ; Li, Zhen ; Huang, Feiruo</creatorcontrib><description>Lactate has recently been reported to accumulate in the livers of patients progressing from simple steatosis to non-alcoholic steatohepatitis (NASH). However, the underlying mechanism(s) of lactate accumulation and the role of lactate in the progression of non-alcoholic fatty liver disease (NAFLD) are essentially unknown. We compared the acetylome in liver samples taken from healthy individuals, patients with simple steatosis and patients with NASH to identify potential targets of acetylation with a role in lactate metabolism. Interactions between the acetylated target and acetyltransferases were measured in multiple cell lines. An acetyltransferase inhibitor was injected into high-fat diet (HFD)-fed mice to determine the role of lactate on NAFLD progression in vivo. Hyperacetylation of lactate dehydrogenase B (LDHB) was found to be associated with lactate accumulation in NAFL and NASH livers in humans and mice. P300/CBP-associated factor (PCAF)-mediated acetylation of LDHB K82 was found to significantly decrease LDHB activity and impair hepatic lactate clearance, resulting in lactate accumulation. Acetylated LDHB induced lactate accumulation which exacerbated lipid deposition and inflammatory responses by activating histone hyperacetylation in HFD-induced NASH. The administration of embelin, a PCAF inhibitor, and the generation of an acetylation-deficient mutant of LDHB ameliorated NASH. PCAF-dependent LDHB acetylation plays a key role in hepatic lipid accumulation and inflammatory responses by impairing lactate clearance; this process might be a potential therapeutic target for the treatment of NASH. Lactate is known to accumulate in the livers of patients during the progression of non-alcoholic fatty liver disease (NAFLD); however, the underlying mechanism(s) of this accumulation and its importance in disease progression are unknown. Herein, we show that the acetylation of an enzyme involved in lactate metabolism leads to impaired lactate clearance and exacerbates NAFLD progression.</description><identifier>ISSN: 0168-8278</identifier><identifier>ISSN: 1600-0641</identifier><identifier>EISSN: 1600-0641</identifier><identifier>DOI: 10.1016/j.jhep.2020.11.028</identifier><identifier>PMID: 33248168</identifier><language>eng</language><publisher>Netherlands: Elsevier Science Ltd</publisher><subject>Acetylation ; Acetyltransferase ; Acetyltransferases - antagonists &amp; inhibitors ; Acetyltransferases - metabolism ; Animals ; Cell Line ; Cell lines ; Deficient mutant ; Dehydrogenases ; Disease Progression ; Fatty liver ; Hepatobiliary Elimination - physiology ; High fat diet ; Histones ; Humans ; Inflammation ; Isoenzymes - metabolism ; L-Lactate dehydrogenase ; L-Lactate Dehydrogenase - metabolism ; Lactic acid ; Lactic Acid - metabolism ; Liver - metabolism ; Liver - pathology ; Liver diseases ; Metabolism ; Mice ; Non-alcoholic Fatty Liver Disease - metabolism ; p300-CBP Transcription Factors - metabolism ; Patients ; Steatosis ; Therapeutic targets ; Tissue Distribution - physiology</subject><ispartof>Journal of hepatology, 2021-05, Vol.74 (5), p.1038</ispartof><rights>Copyright © 2020 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.</rights><rights>Copyright Elsevier Science Ltd. May 2021</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c288t-e122d5eca50b41e440532b35d3bb6d673f6a7636f7b097d00ad9a4db0ad427803</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33248168$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Tongxin</creatorcontrib><creatorcontrib>Chen, Kai</creatorcontrib><creatorcontrib>Yao, Weilei</creatorcontrib><creatorcontrib>Zheng, Ruilong</creatorcontrib><creatorcontrib>He, Qiongyu</creatorcontrib><creatorcontrib>Xia, Jun</creatorcontrib><creatorcontrib>Li, Juan</creatorcontrib><creatorcontrib>Shao, Yafei</creatorcontrib><creatorcontrib>Zhang, Li</creatorcontrib><creatorcontrib>Huang, Lu</creatorcontrib><creatorcontrib>Qin, Longshan</creatorcontrib><creatorcontrib>Xu, Mingming</creatorcontrib><creatorcontrib>Zhang, Zheng</creatorcontrib><creatorcontrib>Pan, Dingyu</creatorcontrib><creatorcontrib>Li, Zhen</creatorcontrib><creatorcontrib>Huang, Feiruo</creatorcontrib><title>Acetylation of lactate dehydrogenase B drives NAFLD progression by impairing lactate clearance</title><title>Journal of hepatology</title><addtitle>J Hepatol</addtitle><description>Lactate has recently been reported to accumulate in the livers of patients progressing from simple steatosis to non-alcoholic steatohepatitis (NASH). However, the underlying mechanism(s) of lactate accumulation and the role of lactate in the progression of non-alcoholic fatty liver disease (NAFLD) are essentially unknown. We compared the acetylome in liver samples taken from healthy individuals, patients with simple steatosis and patients with NASH to identify potential targets of acetylation with a role in lactate metabolism. Interactions between the acetylated target and acetyltransferases were measured in multiple cell lines. An acetyltransferase inhibitor was injected into high-fat diet (HFD)-fed mice to determine the role of lactate on NAFLD progression in vivo. Hyperacetylation of lactate dehydrogenase B (LDHB) was found to be associated with lactate accumulation in NAFL and NASH livers in humans and mice. P300/CBP-associated factor (PCAF)-mediated acetylation of LDHB K82 was found to significantly decrease LDHB activity and impair hepatic lactate clearance, resulting in lactate accumulation. Acetylated LDHB induced lactate accumulation which exacerbated lipid deposition and inflammatory responses by activating histone hyperacetylation in HFD-induced NASH. The administration of embelin, a PCAF inhibitor, and the generation of an acetylation-deficient mutant of LDHB ameliorated NASH. PCAF-dependent LDHB acetylation plays a key role in hepatic lipid accumulation and inflammatory responses by impairing lactate clearance; this process might be a potential therapeutic target for the treatment of NASH. Lactate is known to accumulate in the livers of patients during the progression of non-alcoholic fatty liver disease (NAFLD); however, the underlying mechanism(s) of this accumulation and its importance in disease progression are unknown. Herein, we show that the acetylation of an enzyme involved in lactate metabolism leads to impaired lactate clearance and exacerbates NAFLD progression.</description><subject>Acetylation</subject><subject>Acetyltransferase</subject><subject>Acetyltransferases - antagonists &amp; inhibitors</subject><subject>Acetyltransferases - metabolism</subject><subject>Animals</subject><subject>Cell Line</subject><subject>Cell lines</subject><subject>Deficient mutant</subject><subject>Dehydrogenases</subject><subject>Disease Progression</subject><subject>Fatty liver</subject><subject>Hepatobiliary Elimination - physiology</subject><subject>High fat diet</subject><subject>Histones</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Isoenzymes - metabolism</subject><subject>L-Lactate dehydrogenase</subject><subject>L-Lactate Dehydrogenase - metabolism</subject><subject>Lactic acid</subject><subject>Lactic Acid - metabolism</subject><subject>Liver - metabolism</subject><subject>Liver - pathology</subject><subject>Liver diseases</subject><subject>Metabolism</subject><subject>Mice</subject><subject>Non-alcoholic Fatty Liver Disease - metabolism</subject><subject>p300-CBP Transcription Factors - metabolism</subject><subject>Patients</subject><subject>Steatosis</subject><subject>Therapeutic targets</subject><subject>Tissue Distribution - physiology</subject><issn>0168-8278</issn><issn>1600-0641</issn><issn>1600-0641</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkDtPw0AQhE8IRELgD1AgSzQ0NntP22UIBJAiaKDFOvvWiS2_8NlI_vdcRKCgWmnnm9XsEHJJIaBA1W0ZlDvsAgbMLWgALDoic6oAfFCCHpO5gyI_YmE0I2fWlgDAIRanZMY5E5ET5-RjmeEwVXoo2sZrc6_S2aAH9AzuJtO3W2y0Re_OM33xhdZ7Wa43917nhB6t3XvSySvqThd90Wz_3FmFutdNhufkJNeVxYvDXJD39cPb6snfvD4-r5YbP2NRNPhIGTMSMy0hFRSFAMlZyqXhaaqMCnmudKi4ysMU4tAAaBNrYVI3hXsP-ILc_Nx10T5HtENSFzbDqtINtqNNmFBSiNB149Drf2jZjn3j0iVMSi5VGNM9dXWgxrRGk3R9Uet-Sn6b49925HCA</recordid><startdate>202105</startdate><enddate>202105</enddate><creator>Wang, Tongxin</creator><creator>Chen, Kai</creator><creator>Yao, Weilei</creator><creator>Zheng, Ruilong</creator><creator>He, Qiongyu</creator><creator>Xia, Jun</creator><creator>Li, Juan</creator><creator>Shao, Yafei</creator><creator>Zhang, Li</creator><creator>Huang, Lu</creator><creator>Qin, Longshan</creator><creator>Xu, Mingming</creator><creator>Zhang, Zheng</creator><creator>Pan, Dingyu</creator><creator>Li, Zhen</creator><creator>Huang, Feiruo</creator><general>Elsevier Science Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>202105</creationdate><title>Acetylation of lactate dehydrogenase B drives NAFLD progression by impairing lactate clearance</title><author>Wang, Tongxin ; Chen, Kai ; Yao, Weilei ; Zheng, Ruilong ; He, Qiongyu ; Xia, Jun ; Li, Juan ; Shao, Yafei ; Zhang, Li ; Huang, Lu ; Qin, Longshan ; Xu, Mingming ; Zhang, Zheng ; Pan, Dingyu ; Li, Zhen ; Huang, Feiruo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c288t-e122d5eca50b41e440532b35d3bb6d673f6a7636f7b097d00ad9a4db0ad427803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Acetylation</topic><topic>Acetyltransferase</topic><topic>Acetyltransferases - antagonists &amp; inhibitors</topic><topic>Acetyltransferases - metabolism</topic><topic>Animals</topic><topic>Cell Line</topic><topic>Cell lines</topic><topic>Deficient mutant</topic><topic>Dehydrogenases</topic><topic>Disease Progression</topic><topic>Fatty liver</topic><topic>Hepatobiliary Elimination - physiology</topic><topic>High fat diet</topic><topic>Histones</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Isoenzymes - metabolism</topic><topic>L-Lactate dehydrogenase</topic><topic>L-Lactate Dehydrogenase - metabolism</topic><topic>Lactic acid</topic><topic>Lactic Acid - metabolism</topic><topic>Liver - metabolism</topic><topic>Liver - pathology</topic><topic>Liver diseases</topic><topic>Metabolism</topic><topic>Mice</topic><topic>Non-alcoholic Fatty Liver Disease - metabolism</topic><topic>p300-CBP Transcription Factors - metabolism</topic><topic>Patients</topic><topic>Steatosis</topic><topic>Therapeutic targets</topic><topic>Tissue Distribution - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Tongxin</creatorcontrib><creatorcontrib>Chen, Kai</creatorcontrib><creatorcontrib>Yao, Weilei</creatorcontrib><creatorcontrib>Zheng, Ruilong</creatorcontrib><creatorcontrib>He, Qiongyu</creatorcontrib><creatorcontrib>Xia, Jun</creatorcontrib><creatorcontrib>Li, Juan</creatorcontrib><creatorcontrib>Shao, Yafei</creatorcontrib><creatorcontrib>Zhang, Li</creatorcontrib><creatorcontrib>Huang, Lu</creatorcontrib><creatorcontrib>Qin, Longshan</creatorcontrib><creatorcontrib>Xu, Mingming</creatorcontrib><creatorcontrib>Zhang, Zheng</creatorcontrib><creatorcontrib>Pan, Dingyu</creatorcontrib><creatorcontrib>Li, Zhen</creatorcontrib><creatorcontrib>Huang, Feiruo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Tongxin</au><au>Chen, Kai</au><au>Yao, Weilei</au><au>Zheng, Ruilong</au><au>He, Qiongyu</au><au>Xia, Jun</au><au>Li, Juan</au><au>Shao, Yafei</au><au>Zhang, Li</au><au>Huang, Lu</au><au>Qin, Longshan</au><au>Xu, Mingming</au><au>Zhang, Zheng</au><au>Pan, Dingyu</au><au>Li, Zhen</au><au>Huang, Feiruo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Acetylation of lactate dehydrogenase B drives NAFLD progression by impairing lactate clearance</atitle><jtitle>Journal of hepatology</jtitle><addtitle>J Hepatol</addtitle><date>2021-05</date><risdate>2021</risdate><volume>74</volume><issue>5</issue><spage>1038</spage><pages>1038-</pages><issn>0168-8278</issn><issn>1600-0641</issn><eissn>1600-0641</eissn><abstract>Lactate has recently been reported to accumulate in the livers of patients progressing from simple steatosis to non-alcoholic steatohepatitis (NASH). However, the underlying mechanism(s) of lactate accumulation and the role of lactate in the progression of non-alcoholic fatty liver disease (NAFLD) are essentially unknown. We compared the acetylome in liver samples taken from healthy individuals, patients with simple steatosis and patients with NASH to identify potential targets of acetylation with a role in lactate metabolism. Interactions between the acetylated target and acetyltransferases were measured in multiple cell lines. An acetyltransferase inhibitor was injected into high-fat diet (HFD)-fed mice to determine the role of lactate on NAFLD progression in vivo. Hyperacetylation of lactate dehydrogenase B (LDHB) was found to be associated with lactate accumulation in NAFL and NASH livers in humans and mice. P300/CBP-associated factor (PCAF)-mediated acetylation of LDHB K82 was found to significantly decrease LDHB activity and impair hepatic lactate clearance, resulting in lactate accumulation. Acetylated LDHB induced lactate accumulation which exacerbated lipid deposition and inflammatory responses by activating histone hyperacetylation in HFD-induced NASH. The administration of embelin, a PCAF inhibitor, and the generation of an acetylation-deficient mutant of LDHB ameliorated NASH. PCAF-dependent LDHB acetylation plays a key role in hepatic lipid accumulation and inflammatory responses by impairing lactate clearance; this process might be a potential therapeutic target for the treatment of NASH. Lactate is known to accumulate in the livers of patients during the progression of non-alcoholic fatty liver disease (NAFLD); however, the underlying mechanism(s) of this accumulation and its importance in disease progression are unknown. Herein, we show that the acetylation of an enzyme involved in lactate metabolism leads to impaired lactate clearance and exacerbates NAFLD progression.</abstract><cop>Netherlands</cop><pub>Elsevier Science Ltd</pub><pmid>33248168</pmid><doi>10.1016/j.jhep.2020.11.028</doi></addata></record>
fulltext fulltext
identifier ISSN: 0168-8278
ispartof Journal of hepatology, 2021-05, Vol.74 (5), p.1038
issn 0168-8278
1600-0641
1600-0641
language eng
recordid cdi_proquest_miscellaneous_2465447600
source MEDLINE; Elsevier ScienceDirect Journals
subjects Acetylation
Acetyltransferase
Acetyltransferases - antagonists & inhibitors
Acetyltransferases - metabolism
Animals
Cell Line
Cell lines
Deficient mutant
Dehydrogenases
Disease Progression
Fatty liver
Hepatobiliary Elimination - physiology
High fat diet
Histones
Humans
Inflammation
Isoenzymes - metabolism
L-Lactate dehydrogenase
L-Lactate Dehydrogenase - metabolism
Lactic acid
Lactic Acid - metabolism
Liver - metabolism
Liver - pathology
Liver diseases
Metabolism
Mice
Non-alcoholic Fatty Liver Disease - metabolism
p300-CBP Transcription Factors - metabolism
Patients
Steatosis
Therapeutic targets
Tissue Distribution - physiology
title Acetylation of lactate dehydrogenase B drives NAFLD progression by impairing lactate clearance
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-18T22%3A53%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Acetylation%20of%20lactate%20dehydrogenase%20B%20drives%20NAFLD%20progression%20by%20impairing%20lactate%20clearance&rft.jtitle=Journal%20of%20hepatology&rft.au=Wang,%20Tongxin&rft.date=2021-05&rft.volume=74&rft.issue=5&rft.spage=1038&rft.pages=1038-&rft.issn=0168-8278&rft.eissn=1600-0641&rft_id=info:doi/10.1016/j.jhep.2020.11.028&rft_dat=%3Cproquest_pubme%3E2553567910%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2553567910&rft_id=info:pmid/33248168&rfr_iscdi=true